---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-264616"
form_type: "8-K"
ticker: "TEM"
cik: "0001717115"
company_name: "Tempus AI, Inc."
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:39:35.854519+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Tempus AI Q3 revenue $334M (+84.7% YoY); turns positive adjusted EBITDA; raises FY guidance

## Summary
- Revenue $334.2M, +84.7% YoY; gross profit $209.9M, +98.4% YoY.
- Adjusted EBITDA positive $1.5M vs ($21.8M) loss YoY; net loss ($80.0M) includes $35M stock comp and $12M debt extinguishment loss.
- Genomics revenue $252.9M (+117.2% YoY); Data and services $81.3M (+26.1%).
- 2025 revenue guidance raised to ~$1.265B (~80% growth); Q4 Adj. EBITDA expected ~$20M.
- Acquired Paige (AI digital pathology); 217k clinical tests delivered (+33% YoY).

## SEC filing metadata
- accession: 0001193125-25-264616
- form_type: 8-K
- ticker: TEM
- cik: 0001717115
- company_name: Tempus AI, Inc.
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1717115/000119312525264616/0001193125-25-264616-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1717115/000119312525264616/tem-20251104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-264616
- JSON: https://secwatch.observer/filing/0001193125-25-264616.json
- Plain text: https://secwatch.observer/filing/0001193125-25-264616.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.